These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23069388)

  • 1. Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition.
    Ferreira N; Santos SA; Domingues MR; Saraiva MJ; Almeida MR
    Biochim Biophys Acta; 2013 Jan; 1832(1):39-45. PubMed ID: 23069388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
    Ferreira N; Saraiva MJ; Almeida MR
    PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
    Ferreira N; Saraiva MJ; Almeida MR
    Amyloid; 2012 Jun; 19 Suppl 1():39-42. PubMed ID: 22620965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I; Saraiva MJ
    FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin.
    Teixeira CA; Almeida Mdo R; Saraiva MJ
    Clin Sci (Lond); 2016 Sep; 130(18):1665-75. PubMed ID: 27382986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y; Ore MO; Morin S; Wilson DJ
    Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.
    Macedo B; Batista AR; Ferreira N; Almeida MR; Saraiva MJ
    Biochim Biophys Acta; 2008 Sep; 1782(9):517-22. PubMed ID: 18572024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
    Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD
    Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
    Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
    Ferreira N; Gonçalves NP; Saraiva MJ; Almeida MR
    Sci Rep; 2016 May; 6():26623. PubMed ID: 27197872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis.
    Ferreira N; Saraiva MJ; Almeida MR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.
    Macedo B; Magalhães J; Batista AR; Saraiva MJ
    Pharmacol Res; 2010 Dec; 62(6):514-22. PubMed ID: 20692343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
    Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
    Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and stabilization of transthyretin by curcumin.
    Pullakhandam R; Srinivas PN; Nair MK; Reddy GB
    Arch Biochem Biophys; 2009 May; 485(2):115-9. PubMed ID: 19268650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
    João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
    J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.